Recent federal data released by the Kaiser Family Foundation (KFF) reveal that the cost of health insurance purchased through the Affordable Care Act (ACA) marketplaces has surged dramatically, while claim‑denial rates remain high. For Texas families and Americans nationwide, the numbers underscore a growing dilemma: is the rising premium worth the protection it offers?
Premiums and Deductibles on the Rise
Average monthly premiums for ACA marketplace plans climbed from $113 in 2025 to $178 in 2026 – a 58 percent increase that followed the expiration of enhanced federal tax credits. At the same time, average deductibles rose 37 percent, reaching a record $3,786 per person. KFF attributes much of the deductible jump to consumers shifting from silver plans to lower‑premium bronze plans, which carry higher out‑of‑pocket costs.
Claim‑Denial Rates Remain Significant
Data covering qualified health plans sold through HealthCare.gov in 2024 show insurers denied roughly 19 percent of in‑network claims and 37 percent of out‑of‑network claims, yielding an overall denial rate of about 20 percent. While not every denial is improper, the figures help explain the frustration many consumers feel when a claim is rejected for reasons such as exclusions, perceived medical necessity, or lack of prior authorization.
Prior‑Authorization Landscape
KFF’s August 2026 analysis also examined prior‑authorization denial rates. Across ACA marketplace plans, 18 percent of standard prior‑authorization requests were denied in 2025. UnitedHealth Group, for example, denied 21 percent of such requests in the marketplace, while Elevance Health recorded the lowest rate among large insurers at 4.2 percent. These variations reflect differing insurer policies and the volume of requests each company processes.
Appeals and Reversals
Less than one percent of denied HealthCare.gov claims were appealed internally in 2024, and insurers upheld 66 percent of those challenges. In Medicare Advantage, 11.5 percent of denied prior‑authorization requests were appealed, and insurers reversed 80.7 percent of those decisions, suggesting that many initial denials may lack sufficient documentation.
Cash Payments: A Viable Alternative for Some?
For predictable, non‑emergency services—such as routine office visits, lab work, imaging, or certain prescription drugs—paying cash can sometimes be cheaper than using insurance, especially for patients with high deductibles. Consumers can request a written good‑faith estimate at least three business days before non‑emergency care, and under CMS rules may dispute a final bill that exceeds the estimate by $400 or more.
However, cash payments have drawbacks. They do not count toward deductible or out‑of‑pocket limits, and patients forfeit the negotiated network rates that insurers secure with providers. Moreover, uninsured patients typically pay twice as much for care on average, according to HealthCare.gov.
The Risk of Abandoning Comprehensive Coverage
While cash pricing may make sense for scheduled, low‑risk services, it cannot replace the financial protection offered by comprehensive insurance. In 2026, out‑of‑pocket limits for marketplace plans can reach $10,600 for an individual and $21,200 for a family—figures that still leave many households vulnerable to catastrophic medical expenses.
Experts advise consumers to compare cash and insurance prices for planned services, verify whether cash payments will apply toward any deductible, and obtain written estimates before receiving care. The data suggest that, despite rising costs, maintaining coverage remains a prudent safeguard against unexpected, high‑cost medical events.
Original reporting: WBAP News/Talk (Dallas-Fort Worth) — read the source article.
